The changing paradigm of tumour response to irradiation.
暂无分享,去创建一个
[1] M. Tsao,et al. Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model. , 2016, Clinical lung cancer.
[2] K. E. Visser,et al. Neutrophils in cancer: neutral no more , 2016, Nature Reviews Cancer.
[3] Ping Wang,et al. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. , 2016, Cancer letters.
[4] E. Schröck,et al. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells. , 2016, Cancer research.
[5] P. Tamayo,et al. A genetic basis for the variation in the vulnerability of cancer to DNA damage , 2016, Nature Communications.
[6] F. Pajonk,et al. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status. , 2016, International journal of radiation oncology, biology, physics.
[7] Mechthild Krause,et al. Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.
[8] A. Naghavi,et al. Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future. , 2016, Current problems in cancer.
[9] S. Demaria,et al. Role of Local Radiation Therapy in Cancer Immunotherapy. , 2015, JAMA oncology.
[10] Nawaid Usmani,et al. The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. , 2015, Seminars in radiation oncology.
[11] R. Bristow,et al. Hypoxia and Predicting Radiation Response. , 2015, Seminars in radiation oncology.
[12] C. Drake,et al. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy. , 2015, The Lancet. Oncology.
[13] Drew J. Adams,et al. Radiotherapy in the Era of Precision Medicine. , 2015, Seminars in radiation oncology.
[14] George Yancey Gillespie,et al. Patient-Derived Xenografts as a Model System for Radiation Research. , 2015, Seminars in radiation oncology.
[15] Michael D. Brooks,et al. Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. , 2015, Cell stem cell.
[16] Robert J. Griffin,et al. Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery. , 2015, International journal of radiation oncology, biology, physics.
[17] R. Dacosta,et al. Emerging Applications for Optically Enabled Intravital Microscopic Imaging in Radiobiology , 2015, Molecular imaging.
[18] Zachary C. Dobbin,et al. Ovarian and cervical cancer patient derived xenografts: The past, present, and future. , 2015, Gynecologic oncology.
[19] Kevin J. Harrington,et al. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.
[20] N. Cordes,et al. Focal adhesion signaling and therapy resistance in cancer. , 2015, Seminars in cancer biology.
[21] F. Pajonk,et al. Cancer stem cells, cancer cell plasticity and radiation therapy. , 2015, Seminars in cancer biology.
[22] Yidong Yang,et al. Systematic calibration of an integrated x-ray and optical tomography system for preclinical radiation research. , 2015, Medical physics.
[23] S. C. Chafe,et al. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production. , 2015, Cancer research.
[24] K. D. Castle,et al. Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy , 2015, Science Translational Medicine.
[25] I. Tannock,et al. The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts , 2015, BMC Cancer.
[26] Mina J. Bissell,et al. Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment , 2015, Scientific Reports.
[27] D. Hedley,et al. The clinical significance of hypoxia in human cancers. , 2015, Seminars in nuclear medicine.
[28] J. Visvader,et al. Patient-derived xenograft models of breast cancer and their predictive power , 2015, Breast Cancer Research.
[29] Sabine Tejpar,et al. IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies , 2015, Science Translational Medicine.
[30] H. Kohrt,et al. Current clinical trials testing combinations of immunotherapy and radiation. , 2015, Seminars in radiation oncology.
[31] S. Siva,et al. Abscopal effects of radiation therapy: a clinical review for the radiobiologist. , 2015, Cancer letters.
[32] Andre Dekker,et al. Radiogenomics: the search for genetic predictors of radiotherapy response. , 2014, Future oncology.
[33] Wolfgang Enghardt,et al. Pre-clinical research in small animals using radiotherapy technology--a bidirectional translational approach. , 2014, Zeitschrift fur medizinische Physik.
[34] Igor Jurisica,et al. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. , 2014, The Lancet. Oncology.
[35] C. N. Coleman,et al. Enhancing the efficacy of radiation therapy: premises, promises, and practicality. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] G. Zadeh,et al. VEGF regulates region-specific localization of perivascular bone marrow-derived cells in glioblastoma. , 2014, Cancer research.
[37] Ben Tran,et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.
[38] R. Hill,et al. Hypoxia as a biomarker for radioresistant cancer stem cells , 2014, International journal of radiation biology.
[39] R. Timmerman,et al. Clinical Investigation : Thoracic Cancer No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early-Stage Peripheral Non-Small Cell Lung Cancer : An Analysis of RTOG 0236 , 2022 .
[40] A. Berlin,et al. An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy. , 2014, The British journal of radiology.
[41] D. Tang,et al. Cancer stem cells and radioresistance , 2014, International journal of radiation biology.
[42] David J Brenner,et al. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? , 2014, International journal of radiation oncology, biology, physics.
[43] J. Brown,et al. Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. , 2014, The British journal of radiology.
[44] Manuel Hidalgo,et al. Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.
[45] R. Bristow,et al. Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer. , 2014, Advances in experimental medicine and biology.
[46] P. Iyengar,et al. Stereotactic Ablative Radiotherapy (SABR) for Non–Small Cell Lung Cancer , 2013, Seminars in Respiratory and Critical Care Medicine.
[47] M. Busslinger,et al. GATA-3 REGULATES THE SELF-RENEWAL OF LONG-TERM HEMATOPOIETIC STEM CELLS , 2013, Nature Immunology.
[48] K. Prise,et al. What is the Role of the Bystander Response in Radionuclide Therapies? , 2013, Front. Oncol..
[49] S. Demaria,et al. Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer Treatment , 2013, Front. Oncol..
[50] S. Demaria,et al. Combining radiotherapy and cancer immunotherapy: a paradigm shift. , 2013, Journal of the National Cancer Institute.
[51] C. Koch,et al. Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors. , 2012, Tumor microenvironment and therapy.
[52] Søren M Bentzen,et al. Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news? , 2011, International journal of radiation oncology, biology, physics.
[53] Carl Virtanen,et al. In Vivo Optical Imaging of Tumor and Microvascular Response to Ionizing Radiation , 2012, PloS one.
[54] F. Pajonk,et al. Radiation‐Induced Reprogramming of Breast Cancer Cells , 2012, Stem cells.
[55] Jeong-Won Lee,et al. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. , 2012, Anticancer research.
[56] S. Halford,et al. Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors , 2012, Clinical Cancer Research.
[57] M. M. Elkind,et al. Radiation Response of Mammalian Cells Grown in Culture I. Repair of X-Ray Damage in Surviving Chinese Hamster Cells , 2012, Radiation research.
[58] B. S. Sørensen,et al. Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[59] D. Kirsch. Using Genetically Engineered Mice for Radiation Research , 2011, Radiation research.
[60] M. Wicha,et al. Ablation of breast cancer stem cells with radiation. , 2011, Translational oncology.
[61] Erik Tryggestad,et al. Small animal radiotherapy research platforms , 2011, Physics in medicine and biology.
[62] P. Sykes,et al. Radiation-Induced Bystander Effects: What Are They, and How Relevant Are They to Human Radiation Exposures? , 2011, Radiation research.
[63] W. Wilson,et al. Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.
[64] D A Jaffray,et al. Characterization of image quality and image-guidance performance of a preclinical microirradiator. , 2011, Medical physics.
[65] Mechthild Krause,et al. CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy , 2010, Clinical Cancer Research.
[66] G. Wilson,et al. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. , 2010, International journal of radiation oncology, biology, physics.
[67] W. McBride,et al. Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited , 2010, Stem cells.
[68] H. Vogel,et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. , 2010, The Journal of clinical investigation.
[69] Philippe Lambin,et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.
[70] R. McLendon,et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.
[71] S. Hehlgans,et al. Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[72] Hui Wang,et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.
[73] Irving L. Weissman,et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.
[74] A. Krešo,et al. Cancer stem cells in solid tumors: an overview. , 2009, Seminars in radiation oncology.
[75] D. Chaplin,et al. A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P) , 2009, Expert opinion on investigational drugs.
[76] J. Erler,et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.
[77] B. Wouters,et al. Hypoxia signalling through mTOR and the unfolded protein response in cancer , 2008, Nature Reviews Cancer.
[78] E. Rofstad,et al. Temporal heterogeneity in blood supply in human tumor xenografts. , 2008, Neoplasia.
[79] M. Krause,et al. Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.
[80] Richard P. Hill,et al. Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.
[81] D. Wion,et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. , 2007, Cancer letters.
[82] Jens Overgaard,et al. Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] M. Krause,et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[84] G. Maki,et al. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. , 2007, International journal of radiation oncology, biology, physics.
[85] Frank Pajonk,et al. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. , 2006, Journal of the National Cancer Institute.
[86] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[87] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[88] R. Fisher,et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] R. Sutherland. Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005. , 2006, International journal of radiation oncology, biology, physics.
[90] Chryso Kanthou,et al. Disrupting tumour blood vessels , 2005, Nature Reviews Cancer.
[91] N. Cordes,et al. Integrin Signalling and the Cellular Response to Ionizing Radiation , 2003, Journal of Molecular Histology.
[92] J. Fowler,et al. Loss of biological effect in prolonged fraction delivery. , 2004, International journal of radiation oncology, biology, physics.
[93] M. Horsman,et al. Targeting the tumor vasculature: a strategy to improve radiation therapy , 2004, Expert review of anticancer therapy.
[94] Jian Z. Wang,et al. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). , 2003, International journal of radiation oncology, biology, physics.
[95] Z. Fuks,et al. Radiation and ceramide-induced apoptosis , 2003, Oncogene.
[96] Mikael Karlsson,et al. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[97] N. Iscove,et al. Hematopoietic stem cells engraft in mice with absolute efficiency , 2003, Nature Immunology.
[98] Zvi Fuks,et al. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.
[99] C. Koch,et al. The Km for Radiosensitization of Human Tumor Cells by Oxygen is Much Greater than 3 mmHg and is Further Increased by Elevated Levels of Cysteine , 2001, Radiation research.
[100] P Lambin,et al. Low-dose hypersensitivity: current status and possible mechanisms. , 2001, International journal of radiation oncology, biology, physics.
[101] P. Vaupel,et al. Treatment resistance of solid tumors: role of hypoxia and anemia. , 2001, Medical oncology.
[102] B. Wouters,et al. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.
[103] A. Giaccia,et al. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.
[104] B. Wouters,et al. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.
[105] S. Evans,et al. Cysteine concentrations in rodent tumors: Unexpectedly high values may cause therapy resistance , 1996, International journal of cancer.
[106] M. Dewhirst,et al. Microvascular studies on the origins of perfusion-limited hypoxia. , 1996, The British journal of cancer. Supplement.
[107] J. Hendry,et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[108] S. A. Roberts,et al. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. , 1993, British Journal of Cancer.
[109] W Budach,et al. Impact of stromal sensitivity on radiation response of tumors. , 1993, Journal of the National Cancer Institute.
[110] J. Folkman,et al. The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.
[111] R. James,et al. Lack of a relationship between colony-forming efficiency and surviving fraction at 2 Gy. , 1991, Radiation research.
[112] T. Kwok,et al. The influence of cell-cell contact on radiosensitivity of human squamous carcinoma cells. , 1991, Radiation research.
[113] G. Steel. The ESTRO Breur lecture. Cellular sensitivity to low dose-rate irradiation focuses the problem of tumour radioresistance. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[114] Richard P. Hill,et al. The Basic Science of Oncology , 1989 .
[115] G. Steel. Recovery kinetics deduced from continuous low dose-rate experiments. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[116] L. Milas,et al. The proportion of stem cells in murine tumors. , 1989, International journal of radiation oncology, biology, physics.
[117] C. West,et al. Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. , 1989, International journal of radiation biology.
[118] R. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.
[119] M. Dewhirst,et al. Temporal effects of 5.0 Gy radiation in healing subcutaneous microvasculature of a dorsal flap window chamber. , 1987, Radiation research.
[120] A. Horwich,et al. The dose-rate effect in human tumour cells. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[121] L. Peters,et al. The tumor bed effect: dependence of tumor take, growth rate, and metastasis on the time interval between irradiation and tumor cell transplantation. , 1987, International journal of radiation oncology, biology, physics.
[122] R. Hill. Sensitizers and radiation dose fractionation: results and interpretations. , 1986, International journal of radiation oncology, biology, physics.
[123] S B Curtis,et al. Lethal and potentially lethal lesions induced by radiation--a unified repair model. , 1986, Radiation research.
[124] T C Stephens,et al. Dose-rate effects and the repair of radiation damage. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[125] B. Fertil,et al. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. , 1985, International journal of radiation oncology, biology, physics.
[126] G. Steel,et al. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[127] Hewitt Hb. Second point: animal tumor models and their relevance to human tumor immunology. , 1983 .
[128] R. Hill. Radiation-induced changes in the in vivo growth rate of KHT sarcoma cells: implications for the comparison of growth delay and cell survival. , 1980, Radiation research.
[129] J. Hendry,et al. The Approximation in the Formulation for Survival S = exp − (αD + βD2) , 1980 .
[130] J. Hendry,et al. The approximation in the formulation for survival S=exp-(alpha D + beta D2). , 1980, International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine.
[131] L. Peters,et al. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. , 1979, Journal of the National Cancer Institute.
[132] H. Hewitt,et al. A critical examination of the foundations of immunotherapy for cancer. , 1979, Clinical radiology.
[133] B. Warren,et al. The effect of intercellular contact on the radiation sensitivity of KHT sarcoma cells. , 1979, Radiation research.
[134] G. Barendsen,et al. The Proliferative Status And Clonogenic Capacity Of Tumour Cells In A Transplantable Rhabdomyosarcoma Of The Rat Before And After Irradiation With 800 Rad Of X‐Rays , 1978, Cell and tissue kinetics.
[135] L. Milas. Effects of C. parvum on radiation response of murine tumors. , 1977, Developments in biological standardization.
[136] H. Suit,et al. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors , 1976, Cancer.
[137] J F Fowler,et al. The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. , 1976, Radiation research.
[138] G. Adams,et al. Time-resolved oxygen effects in irradiated bacteria and mammalian cells: a rapid-mix study. , 1975, Radiation research.
[139] J. Fowler,et al. The effect of single and fractionated doses of x rays on the effective proportion of hypoxic cells in C 3 H mouse mammary tumours. , 1972, The British journal of radiology.
[140] R. Sutherland,et al. Effects of intercellular contact on repair of radiation damage. , 1972, Experimental cell research.
[141] N. J. McNally,et al. Recovery from sub-lethal damage by hypoxic tumour cells in vivo. , 1972, The British journal of radiology.
[142] R. Hill,et al. The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. , 1971, The British journal of radiology.
[143] H. Suit,et al. Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma. , 1971, Radiation research.
[144] L. V. van Putten,et al. Oxygenation status of a transplantable tumor during fractionated radiation therapy. , 1968, Journal of the National Cancer Institute.
[145] R. E. Ellis,et al. The response of C3H mammary tumours to irradiation in single and fractionated doses. , 1968, The British journal of radiology.
[146] W. K. Sinclair. Cyclic x-ray responses in mammalian cells in vitro. , 1968, Radiation research.
[147] R. Thomlinson,et al. The gross response of an experimental tumour to single doses of x-rays. , 1967, British Journal of Cancer.
[148] L. Tolmach,et al. DEMONSTRATION OF AN ANOXIC COMPONENT IN A MOUSE TUMOR-CELL POPULATION BY IN VIVO ASSAY OF SURVIVAL FOLLOWING IRRADIATION. , 1964, Radiology.
[149] H. Suit,et al. RESPONSE OF SPONTANEOUS MAMMARY CARCINOMA OF THE C3H MOUSE TO X IRRADIATION GIVEN UNDER CONDITIONS OF LOCAL TISSUE ANOXIA. , 1963, Journal of the National Cancer Institute.
[150] Gray Lh. Radiobiologic basis of oxygen as a modifying factor in radiation therapy. , 1961 .
[151] L. H. Gray. Radiobiologic basis of oxygen as a modifying factor in radiation therapy. , 1961, The American journal of roentgenology, radium therapy, and nuclear medicine.
[152] H. Sutton,et al. Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. , 1960, Radiation research.